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Members of the public are increasingly consulted over health care and research priorities. Patient involvement in determining cancer
research priorities, however, has remained underdeveloped. This paper presents the findings of the first consultation to be conducted
with UK cancer patients concerning research priorities. The study adopted a participatory approach using a collaborative model that
sought joint ownership of the study with people affected by cancer. An exploratory, qualitative approach was used. Consultation
groups were the main method, combining focus group and nominal group techniques. Seventeen groups were held with a total of
105 patients broadly representative of the UK cancer population. Fifteen areas for research were identified. Top priority areas
included the impact cancer has on life, how to live with cancer and related support issues; risk factors and causes of cancer; early
detection and prevention. Although biological and treatment related aspects of science were identified as important, patients rated
the management of practical, social and emotional issues as a higher priority. There is a mismatch between the research priorities
identified by participants and the current UK research portfolio. Current research activity should be broadened to reflect the priorities
of people affected by the disease.
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Patient engagement in the development and monitoring of health
services and in the conduct of health research has increased in
importance in recent decades. The UK government’s commitment
to patient involvement is evident with the publication of
documents such as Choosing Health and Our health, our care,
our say (Department of Health, 2004, 2006). Similarly, the
involvement of service users is seen to be an important part of
good research practice (Department of Health, 2005) and the
advantages of patient engagement are well documented (Gray et al,
2000; Tallon et al, 2000; Hanley et al, 2003). Recent guidelines have
recommended involving service users at every stage of the research
process from identifying research priorities through data collec-
tion and analysis to the dissemination of findings (Hanley et al,
2003). Involving patients in setting the research agenda is
particularly important as their views may differ from current
research practice and are more likely to reflect the interests of the
general public and thus health care, public health and social care
services (Tallon et al, 2000; Hanley et al, 2003). Furthermore, the
legitimacy and sustainability of investment decisions made by
research funding bodies will increasingly depend on how well they
reflect the underlying values of the public (Maxwell et al, 2003).
Patient engagement in determining research priorities remains a
developing field of study, particularly in cancer research (Lomas
et al, 2003; Corner and Wright, 2004; Oliver et al, 2004). To date,
there has been no comprehensive attempt to elicit patients’ views
to inform the strategic direction for cancer research on a UK wide
basis (Corner and Wright, 2004). Strategies for research funding
decision-making are multifaceted and involve considerations such
as the critical appraisal of research questions and the relative
importance of the studies. It has been suggested that economic
constraints result in a preference for cost–benefit analyses above
patient-derived prioritisation methods (Stewart, 1995; Liberati,
1997). However, there is growing recognition that research has to
respond to the needs of service users as well as the professionals’
agenda (Tierney, 1998).
Priorities for cancer research in the UK have traditionally been
determined by individual funding bodies, usually involving the
scientific community. Questions have been raised in recent years
over the extent to which people affected by cancer should be
involved in setting the research agenda. A study conducted by the
US National Cancer Institute, for example, found that patients
were critical of how research priorities are determined despite
being supportive of cancer research (Jenks, 1997). Similarly in the
UK, involving people affected by cancer in setting research
priorities has been seen to be a means of improving public
confidence in cancer research (Glass, 2002).
In light of the limited understanding of the research agendas of
people affected by cancer, Macmillan Cancer Support initiated the
first study to involve cancer patients across the UK in identifying
priorities for research investment. The study was supported by the
UK National Cancer Research Institute. This paper presents the
key findings from this work.
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sMATERIALS AND METHODS
Given the interest in patient derived priorities for research, it was
considered appropriate to adopt a participatory approach as the
theoretical frame of reference for the study (Parkes and Panelli,
2001; Reason and Bradbury, 2001; Wright et al, 2006). Participa-
tory research sees research as a democratic process where
participants are active citizens rather than passive ‘subjects’
(Reason and Bradbury, 2001). Consequently, all elements of the
study were developed and designed in consultation with a
reference group comprising patient and carer representatives and
a stakeholder group representing patient interest groups and
major research funding bodies. Patient and carer representatives
were approached through the user partnership groups of the
cancer networks located across the UK. In addition, community
representatives from under-researched sections of society were
also involved through participating sites and national organisa-
tions. Fifteen patients and carers from the reference group became
co-researchers and received training and support to collect data
and conduct analysis with the Macmillan Research Unit (Wright
et al, 2006). The co-researchers ‘co-owned’ the study with the Unit,
and as such had a direct influence on all aspects of the study,
including data collection, analysis and dissemination of study
findings. Inevitably the level of research knowledge and experience
differed between co-researchers and professional researchers, and
this was managed through the ongoing negotiation of the
respective roles and responsibilities; co-researchers undertook
greater responsibility as they gained in confidence and expertise.
The participatory approach was successful as a vehicle to engaging
cancer patients in discussions about research priorities, and
participants valued the data collection being co-led by someone
who had experienced cancer themselves. A more detailed
description of their involvement in the study has been published
elsewhere (Wright et al, 2006).
Consultation groups were the main method of data collection,
which combined a focus group approach with an adapted Nominal
Group Technique. Focus groups were appropriate as they allowed
patients themselves to set the boundaries of what they perceived to
be legitimate avenues for research. This is necessary in studies
where limited research evidence necessitates an exploratory
approach (Krueger, 1994). However, unlike typical focus groups,
the discussion was structured by using an amended Nominal
Group Technique (NGT). The amended NGT was adopted in order
to achieve consensus over research priorities. Nominal Group
Techniques were developed to aid community decision-making
and are particularly helpful in generating ideas and priorities in
situations where participants are likely to have diverse views on a
subject where little is known (Murphy et al, 1998). They also
prevent dominant participants from controlling the group discus-
sion and allow participants to raise views and opinions in a
manner protected from the direct rejection of other participants
(Wellings et al, 2000).
Nominal Group Techniques have been successfully applied to
various areas of health research (Campbell and Cantrill, 2001;
Telford et al, 2004) and have been used specifically to identify
research priorities (Duncan et al, 2003). Nominal groups typically
involve participants recording ideas independently and in private,
then sharing, listing and discussing the ideas, and finally judging
or voting on the ideas independently. It is usual for participants to
be asked to identify issues before attending the NGT session.
However, as Aspinal et al (2006) discuss, in studies where sensitive
issues may be raised, it is preferable to modify the NGT to limit
prior preparation. Thus, all ideas were generated within the group
to reflect the particular needs of the participants. Figure 1 details
the format of group discussions.
Consultation groups lasted approximately 1.5–2h and were held
at a mutually convenient local venue, such as the cancer centre. A
stakeholder panel advised on the nature of the consultation
groups, as recommended by Lomas et al (2003). A patient/carer
co-researcher and a member of the research team jointly
moderated the consultation groups. Another patient/carer co-
researcher acted as an observer in most consultation groups.
Group discussions were tape recorded and subsequently tran-
scribed verbatim. Training for the co-researchers was extensive
and involved issues such as avoiding leading questions, encoura-
ging discussion from all participants and being reflective of the
potential impact of the researcher on the discussion, thus helping
to maintain the quality of the data (Wright et al, 2006).
Ethical approval for the study was gained through the South East
Multi-Centre Research Ethics Committee. Local Research and
Development Governance approval was secured according to local
requirements in each study setting. All participants gave written
consent to participate.
Participants
The study sought to elicit the views of ‘unorganised’ (as opposed to
self-selecting and ‘expert’) cancer patients (Maxwell et al, 2003).
Hence, participants (X18 years) were recruited through outpatient
clinics in seven cancer centres across the UK on a sequential basis
using a population sample stratified by gender and stage of
treatment. There was a maximum of four breast cancer patients
per group so that a broad range of demographic characteristics
and cancer types were represented. Patients were excluded from
the study if they were deemed by the research nurse or other
members of the clinical team to be too unwell, have complicating
health factors or liable to be distressed by study participation. All
other potential participants were invited to participate regardless
of prior involvement in research.
To ensure that people from diverse communities and back-
grounds were included, consultation groups were also run
with purposively selected participants from frequently under-
researched communities. These included two consultation groups
with participants from a South Asian cancer support group
conducted in English, Hindi and Gujarati, a consultation group
with people aged over 75 years and two consultation groups with
people with advanced cancer recruited from day care services in
two hospices.
Analysis
As the purpose of the study was to reach consensus over priorities
for cancer research through the application of a nominal group
• Introductory questions: Participants discussed previous involvement in 
research and how they accessed research information. This facilitated an 
introduction to discussion about research. 
• Transition questions: Participants discussed their general 
understanding, knowledge and perceptions of cancer research. This was 
designed to focus thinking about cancer research, leading to a discussion 
of what should be researched. 
• Key questions / Nominal group technique: Participants were asked to 
write research topics they felt to be important on ‘post-it’ notes, these were 
then shared with the group and then clustered by the participants into 
related areas of research. At this point, participants were invited to give 
their rationale for their research interests (refer to Table 3). Each 
participant was then given the opportunity to cast three votes to identify 
independently the research area(s) they felt to be most important. They 
were permitted to use their votes for a single research area or for more 
than one research area. 
• Ending questions: The priorities identified through the voting process 
were then fed back to the group and discussed. This enabled an effective 
summary of the discussion and also permitted any additional views not 
covered in the consultation group to be raised. 
• A short questionnaire was given to all participants to detail their 
experiences of taking part in the consultation group and to indicate if they 
had any views or priority areas not discussed in the group. 
Figure 1 Process of identifying research priorities in consultation groups.
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stechnique, this was the focus for the analysis. The consultation
groups generated two forms of data: a ranked list of research topics
and questions arranged into themes within each consultation
group by participants, and transcripts of recorded discussion. The
transcripts provided contextual data regarding the meaning of
research topics as well as participants’ rationale for identifying
them as important.
To develop a composite list of research themes across all 17
consultation groups, a process for grouping similar clusters of
research topics was undertaken using a form of thematic analysis
(Strauss, 1987). DW analysed all 17 research priority lists generating
a name for each cluster of research topics. Nested themes were
identified under higher order themes. The reliability of the analysis
was assessed through a process of independent assessment of all
priority lists involving two members of the research team and five
patient/carer co-researchers (four involved in data collection and
one not). Transcripts of consultation groups were consulted where
research ideas were unclear. With few exceptions, the independent
analysts agreed on the names generated.
The ranked lists of research themes for the 17 consultation
groups were then combined taking into account the ranked scores
of each theme within each group. The ranked scores within each
consultation group have a possible range from 1 (for the research
theme receiving the least votes) to 6 (for the research theme
receiving the most votes. Six was the maximum number of
research theme clusters identified during the vote casting exercise
in any consultation group). Therefore, the highest score possible
from this exercise across all 17 groups is 102 (6 17¼102) for any
given theme. A higher score indicates a larger number of votes.
The consultation group transcripts were also subjected to
thematic analysis. This was appropriate given the need to
contextualise the identified research priorities. Data analysis
occurred iteratively and a process of progressive focussing
occurred whereby topics identified through an initial reading of
the interview transcripts were clustered into a set of emerging
themes (Hammersley and Atkinson, 1989). After this, the range of
responses relating to individual themes was identified and then
organised into subthemes. DW analysed all transcripts and was
verified by the co-researchers and through independent analysis of
six transcripts by two researchers who met initially to devise a
coding framework and then continued to analyse a subset of the
transcripts. Again, with few exceptions, there was close agreement
between the analyses. Data were managed and retrieved using
NUD*IST 6 software.
RESULTS
Participants
A total of 17 consultation groups were conducted with 105
participants with a median of 6 (range 3–11) participants in each.
An audit of recruitment was undertaken in six participating
centres. Across these sites, 379 patients were approached of which
80 (21.1%) participated in the consultation groups. Men were more
likely to decline, almost one-third of patients were male, despite
being oversampled during recruitment (n¼33, 31.4%). A common
reason for refusal was not wishing to share views in a group.
Participants had a range of cancer types and sites and 11.4% of
participants were from Black Caribbean and South Asian Groups
(n¼12) (Table 1). Forty-six participants (43.8%) indicated that
they had been involved in research before taking part in the study,
most of who had been involved in clinical drug trials.
Research priorities
Fifteen research themes were generated in the consultation groups
(Table 2). Table 3 illustrates each of these themes with reference to
excerpts from consultation group transcripts. In most consultation
groups, consensus over research priorities was easily attained.
There were rare occasions, however, where consensus was not
reached. These were documented in the analysis.
Impact on life, how to live with cancer and related support
issues The highest priority for future research identified by
consultation group participants was research into the ‘impact on
life, how to live with cancer and related support issues’. This broad
theme included psychological consequences of cancer (impact on
the patient or others, the influence of mental attitude on recovery);
support groups (evidence of effectiveness) and after-care (the need
for improved after care as well as outcomes of care); the impact
cancer has on social functioning (such as driving, travelling,
shopping); employment and financial issues (difficulty for patients
gaining employment, re-entering the workplace or continuing
work following treatment, the financial cost of cancer in terms of
treatment, insurance and benefits).
There was little discussion of symptoms, although pain
management was raised in several consultation groups and in
one palliative care group in particular. Greater priority was given
to how patients could manage cancer themselves, particularly in
the area of diet and general lifestyle.
Group discussions revealed the rationale for prioritising
research on the impact of cancer on life so highly. It was felt
important to document the challenges experienced by cancer
patients and their families, and to identify means of improving
quality of life and the quality of care:
‘I would love for somebody to come andy find out how we are
all coping and the reasons why we are coping. What are the
reasons why we are not coping? Could it be that we are having
bad experiences in hospital?. Could it be that we are having
difficulties at home because our partners can’t cope and are
taking it out on us in some way?. And so, just that small study
would be of enormous interest, I think, to the people who plan
Table 1 Participant data
Participant data N¼105 (%)
Gender
Male 33 (31.4)
Female 72 (68.6)
Age
30–39 4 (3.8)
40–49 10 (9.5)
50–59 25 (23.8)
60–69 28 (26.7)
70+ 23 (21.9)
Tumour site
Breast 22 (21.0)
Gynaecological 23 (21.9)
Gastrointestinal 19 (18.1)
Prostate 4 (3.8)
Haematological malignancies 8 (7.6)
Lung 9 (8.6)
Other 6 (5.7)
Treatment information
On treatment 17 (16.2)
Off treatment 58 (55.2)
Palliative (hospice) 14 (13.3)
Unavailable data are a result of a range of factors including data not being held at the
participating site (such as the support group) or because participating sites were
unable to provide the data.
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sand deliver our care.’ (Linda, Breast Cancer Patient, Mixed
Consultation Group)
Participants believed the emphasis in research had centred on
developing cancer treatments whereas the experience of managing
the impact of cancer on individuals was felt to have been relatively
neglected. In contrast, though most participants had undergone
cancer treatment, research into cancer treatment was ranked
seventh alongside research into the management of side effects of
treatment and different cancer types. Participants often felt that,
while the drive of medical research was to discover new treatments
for cancer, research into the cost of cancer and cancer treatment to
the individual received less attention. Hence, participants called
for a balance in research effort so that the personal consequences
of cancer are also addressed.
Risk factors and causes Risk factors and causes was the second
highest priority. Four main areas of concern were raised: the
environment, genetics, diet and stress (Table 3). Environmental
issues related to general concerns, such as air pollution, electricity
pylons and nuclear power stations and the everyday use of
potentially harmful devices, such as mobile phones, TVs,
computers, microwave ovens and aerosols. Diet was raised as a
possible causal factor in cancer and also whether periods of high
anxiety and stress could be a contributing factor. A common
question raised was whether family members needed to be tested
after a diagnosis of cancer and to know if their cancer diagnosis
was related to previous cancers in the family. Research into
genetics and family history was related to early detection and
screening.
Risk factors and causes was a priority for participants as they
had a personal interest in what caused their cancer and believed
that identifying causes was an essential part of preventing cancer.
Participants often justified this priority by reflecting on potential
causes for their own cancer:
‘There must be ongoing research into these electricity pylonsy
I know a particular pylon where I used to livey A friend of
mine who moved from there, he’s got prostate cancer, a lady
who bought his house from him near that pylon died from
cancer. Just up the road from where I used to live, the next
house up, the husband and the wife in their early fifties both
had Hodgkin’s or non Hodgkin’s. Somebody else in that road
had cancer, I live sixty yards down the road, I’ve had cancer.
What’s in the ground, is there a stream with something running
through?’ (Jim, Bowel Cancer Patient, Mixed Group)
Early detection and prevention Early detection and prevention
was the third highest priority theme. Cancer prevention was seen
in three ways: an avoidance of risk factors, the detection of cancer
at a precancerous stage and the prevention of cancer from
advancing to a more aggressive state after diagnosis (Table 3).
Participants suggested that research should identify and develop
measures and techniques to identify particular cancers easily and
effectively. A significant area of concern was the role of primary
care and the GP in detecting cancer early. Research into diet as a
means of cancer prevention was identified. In particular, there was
a view that certain food types may prevent cancer and participants
wanted to see research evidence to support this.
Many participants felt that preventative research should take
precedence over other types of research, as ‘prevention is better
than cure’. Cancer prevention was prioritised as it was felt that
research into this area would prevent the impact of the disease on
the patient and the resource implications of treatment:
A cure could be very expensive, lots of medical resources, but
prevention, if you can nip a thing before it even starts, nip it in the
bud, it’s much better than having to go into hospital and maybe
having major surgery and all the follow-up treatment that you
need. (Stella, Breast Cancer Patient, Mixed Consultation Group)
DISCUSSION
Our study illustrates that, contrary to common perceptions
(Hanley et al, 2003), cancer patients are able to engage with a
broad range of issues relating to science, medicine, health and
social care, the purpose and value of cancer research and can
identify and agree on priorities. The highest priority area did not
differ markedly across groups, including those that specifically
targeted older patients, patients from South Asian communities or
patients with advanced cancer.
Our findings reflect those of research prioritisation studies
conducted in areas other than cancer in that the priorities of
patients differed from current research activity. Two of the three
highest priorities for patients identified in this study comprise
around 4% (supportive and palliative care) and 12% (early
detection and prevention) of UK cancer research funding, with
Table 2 Research themes and ranked scores of research themes identified in consultation groups
Rank Key theme
Total rank score
(possible range: 1–102)
Number of
consultation groups in
which topic received at
least one vote N¼17
1 Impact on life, how to live with cancer and related support issues 68 13
2 Risk factors and causes 58 12
3 Early detection and prevention 48 9
4 Research into general information needs (on cancer, treatment, research and access to) 34 11
5 Use and effectiveness of complementary and alternative therapies 30 7
6 General education of public about cancer 24 5
7 Research into different cancer and patient types 23 7
7 Research on treatment (curative treatment, treatment types and improvements) 23 5
7 Experiences and management of side effects 23 7
8 Organisation and funding of health and social care services 21 6
9 Coordination, impact and funding of research 19 4
10 Research into recurrence 11 3
11 General communication issues involving all parties 10 3
12 Accessing patients’ views about cancer, services and research 9 2
13 Health and safety in the hospital 1 1
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sTable 3 Excerpts from transcripts illustrating rationale for research ideas and priorities identified in consultation groups
Research priority Subthemes Illustrative quotes from consultation group transcripts
a
Research priority 1: impact on life, how
to live with cancer and related support
issues
K Psychological consequences
K Self-help groups and peer support
K Follow-up and after care
K Impact on social
K Functioning
K Work and other financial impacts
K Pain management
K Impact on family and others
K Diet and other issues in managing cancer
‘It’s not just about getting a stethoscope or dissecting things and
looking at it, it’s about things like aromatherapy and counselling for
people with progressive or terminal illnesses. So it’s not just about the
actual tumour or the after effects of your operation, it’s more, it’s how
you feel, whether or not you get depression, whether or not you’re
worried if it’s going to go onto your family, all of that needs to be
researched.’ (Liz, Colon Cancer Patient, Mixed Consultation Group)
‘I think money has to be a priority for research because, at the end of
the day, we can’t exist without finances and it is bad enough having
cancer but there is probably only one thing worse than having cancer
and that is having cancer with no money.’ (Kevin, Lung Cancer Patent,
Mixed Consultation Group)
‘I would like more research done into [diet], just sensible suggestions,
maybe unproven scientificallyy the information I’m picking up,
increasingly I think it will become one of the major ways of preventing
as well as controlling cancer and maybe, I’d like a booklet that would
encourage people to go away and eat healthily.’ (Ingrid, Ovarian
Cancer Patient, Mixed Consultation Group)
Research Priority 2: Risk factors and
causes
K Environmental
K Genetic
K Diet
K Stress
K Other
‘There must be research into electricity pylons. I know a particular
pylon where I used to live and loads of people contracted cancer...
What’s in the ground, is there a stream with something running
through I don’t know?’ (Jim, Bowel Cancer Patient, Mixed
Consultation Group)
‘The hereditary thing worries me and I think it should be
researchedy I have three grandchildren and I have been questioned,
‘‘Is this hereditary?’’ You know, I can’t answer that.’ (Stephanie, Bowel
Cancer Patient, Mixed Consultation Group)
‘My aunty had a bad car accident with her neck years ago, when there
weren’t any seatbelts and she developed throat cancer, so you often
wonder whether trauma caused it.’ (Sophie, Breast Cancer Patient,
Mixed Consultation Group)
Research Priority 3: Early detection and
prevention
K Early diagnosis, detection and prevention.
K GP awareness, knowledge and training, and related issues.
K Means of prevention (e.g. diet)
‘Far better for a very long term outlook than fiddling around with
cancer treatments. Sufferers as we are, we’re interested in having
research into effective treatments as well, but I think a fair bit of
research money was directed into causes and therefore prevention of
cancer by trying to eliminate the causes or educate people to avoid
the causes.’ (Susan, Ovarian Cancer Patient, Mixed Consultation
Group)
‘Well, I would also add that we could have more research into diet,
because we read, if you eat 4lbs of beetroot every day, then it stops
this, that and the other. A lot of it’s rubbish, but is there any sort of
research into diet that could be beneficial?’ (Elizabeth, Patient
receiving palliative care services, Palliative Care Consultation Group)
Research Priorities 4 - 15 K General information needs
K Use and effectiveness of CAM
K General education of public
K Research into different cancer and patient types
K Research on treatment
K Experiences and management of side effects
K Organisation and funding of health and social care
services
K Coordination, impact and funding of research
K Research into recurrence
K General communication issues
K Accessing patients’ views about cancer, services and
research
K Health and safety
‘Ovarian cancer is supposed to be without any symptoms, but it isn’t
and I think if you asked a hundred people who have had ovarian
cancer, ‘‘What exactly did you feel like, and what happened to you?’’,
and they’d say about the weight increase and you might get some idea
of what the symptoms are. I don’t believe it’s without symptoms. I
know it isn’t and I think it’s only education and publicity that will do
this.’ (Tracy, Ovarian Cancer Patient, Mixed Consultation Group)
‘I hate to use the cliche ´, but something like looking out for new cures,
sort of blue sky research. I think that’s important.’ (Philip, Patient
receiving palliative care services, Palliative Care Consultation Group)
‘‘There’s such a plethora of research bodies, why isn’t there a national
integration? It’s like anything else, they’re all vying for one thingy why
cannot we draw the line together and have some sort of national co-
ordinating body that directs research where it should take place and
get an equitable playing field?’ (Colin, Pancreatic Cancer Patient,
Mixed Consultation Group)
‘‘I think you’ve got to be careful to centralise, if you pool resources,
then the trouble is you don’t necessarily get the diversity of ideas that
are being put forward. If you start to centralise things too much, then
lateral thinking can go out the window, because one research centre
will pursue one line and another one will pursue another. Now one
might be no good, but if they’re all doing the same thing and it was the
wrong idea, you know.’ (Steven, Bowel Cancer Patient, Mixed
Consultation Group)
‘‘Maybe research [should go] into why you get a reoccurrencey why
does it reoccur, maybe twenty years later or fifteen years later?’
(Kirsty, Breast Cancer Patient, Mixed Consultation Group)
aPseudonyms are used in place of participant names throughout this paper.
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scancer biology comprising 43% (National Cancer Research
Institute, 2004). Patients’ concerns primarily lie with the need
for assistance with what it means to live day to day with cancer,
which they feel is lacking, and not, as one might expect, with
finding the most effective treatments for cancer. The reason for the
emphasis placed on how cancer impacts on daily life may be
because patients are well aware of the significant activity underway
in research into new cancer treatments, but feel that their other
needs are not being addressed.
Decisions around investment in research by funding bodies has,
to date, largely been determined through the generation of
research topics from within the biomedical community and this
accounts for the relative imbalance in research monies allocated to
addressing the priorities of patients. There are also few incentives
for pursuing research into the impact of cancer on life as
discoveries or developments in this area are not high profile in
academic or scientific communities and do not lead to inventions
or technologies that can be exploited commercially. This may also
account for why a relatively small proportion of funding is
allocated to the public health imperatives of causation, prevention
and screening. The involvement of patients in setting priorities for
research funding might involve a significantly increased invest-
ment in these areas.
Although a large body of research has been undertaken into the
psychological consequences of cancer and into quality of life
during cancer treatment, this clearly has not been made available
to people with cancer themselves as this study reveals they are not
aware of its existence.
The second priority area, ‘risk factors and causes’, has some
parallels with the greatest area of research activity in the UK
(cancer biology). However, patients refer to concerns relating to
environmental and hereditary factors rather than research into the
biology of carcinogenesis per se although this may be due to the
highly specialised nature of cancer science, knowledge of which is
not available to most lay people. A need to develop greater
understanding of cancer science among the public and patients is
indicated.
The findings of this study support those of the US National
Cancer Institute; some patients are critical about how research
priorities are made (Jenks, 1997). There are parallels here with
AIDS activism where the boundaries of science and motivations of
the medical and scientific communities have been challenged by
patients (Epstein, 1996, 1997). As in the case of AIDS, this study
raises the question as to who should have a seat at the table when
determining decisions about investment in cancer research and
demands that cancer research is made more democratic and more
accessible to the communities it seeks to serve (Martin, 1980;
Porter, 1997). It has been suggested that engaging with commu-
nities more effectively can rectify the mistrust of research and thus
improve the conduct and outcomes of research (Newman, 2006).
Limitations
The study has limitations. Given the paucity of literature on the
research priorities of people affected by cancer, it was necessary to
undertake an exploratory study. This was successful in allowing
participants to raise their own issues but limited the population
sample of the study. Further research is therefore required to
assess the generalisability of findings across a larger population. In
particular, 20% of patients, fewer men than women and few
patients with aggressive tumours, such as lung or pancreatic
cancer, participated in the consultation. Participants from
minority ethnic backgrounds were underrepresented in the
recruitment from cancer centres. Although South Asian partici-
pants were recruited through patient support groups, these
participants were less typical than patients recruited through the
centres. Participants were patients attending cancer treatment
settings as well as palliative care services, and while there was
substantial consensus over research priorities among the range of
patients who participated it may be that individual views change
over time. This study did not set out to ascertain the views of
people who do not have cancer or people who have been bereaved
as a result of cancer, nor does it reflect the views of patients in
other contexts such as resource poor countries. It may be
important to know how the views of such individuals differ from
the perspectives of these patients. Although consultation groups
led by patients and carers were highly valued by participants, it is
possible that this influenced the discussion in consultation groups
and in turn the topics generated as priorities.
CONCLUSION
This study indicates the importance of involving patients and the
public in the identification of strategic priorities for research. As
the beneficiaries of discoveries and developments in cancer
science, it cannot be assumed that their views will automatically
accord with those of the scientific community. It would appear that
patients with cancer, regardless of their personal situation have
clear views as to the most important priorities for research
investment. Their highest ranked concerns are not currently being
addressed. In addition, dissemination of research findings to
patients is currently inadequate.
A clear direction for the future agenda for cancer research is
indicated whereby a better balance is achieved between research
into the causes of the disease and treatments and research that
helps people to live with illness and its consequences. Further-
more, it is evident there is a need to consider the views of patients
alongside traditional strategies for research prioritisation when
making funding decisions in the future. Research funding bodies
and the scientific community must consider how they will respond
to the priorities of patients.
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